GT Biopharma, Inc.(NasdaqCM:GTBP) dropped from Russell Microcap Growth Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | +8.27% |
|
-2.37% | -62.35% |
Jun. 27 | GT Biopharma Says FDA Clears Investigational New Drug Application for Cancer Drug GTB-3650 | MT |
Jun. 27 | GT Biopharma Shares Rise on FDA Clearance for Cancer-Drug Study | DJ |
1st Jan change | Capi. | |
---|---|---|
-62.35% | 6.21M | |
+55.55% | 816B | |
+39.12% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.42% | 238B | |
+1.06% | 222B | |
+13.61% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- GTBP Stock
- News GT Biopharma, Inc.
- GT Biopharma, Inc.(NasdaqCM: GTBP) dropped from Russell Microcap Growth Index